Lilly Just Huge Vote: Morgan Stanley Bets on Mounjaro
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...
Learn about the key financial habits for success that can pave the way to wealth. Start building these habits today!
26,788 articlesA major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...
Adobe's 2026 earnings trajectory hinges on subscription momentum, AI-enabled products, and disciplined costs. This gu...
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
OpenAI’s fresh developments could tilt the landscape for AI hardware suppliers. This guide explains what Broadcom sto...
Two fast-food giants shape the investing landscape with very different revenue engines. This analysis dives into how ...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
The weight loss therapy wave has fireworks at the giants, but smart investors look for underrated weight loss stocks ...
A SpaceX IPO could reshape growth investing, creating upside for Rivian and other high-growth names. This guide break...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
When a biotech deal moves a small cap, it can set the tone for the whole sector. This story explains what happened wi...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...